Google
AllShoppingImagesNews Maps Videos Books
Search tools
Past week
  • Recent
  • Past hour
  • Past 24 hours
  • Past week
  • Past month
  • Past year
  • Archives
Sorted by date
Clear

SCLX Beats on Earnings as Product Line Expands

MSN
By Brad Sorensen, CFA NASDAQ:SCLX READ THE FULL SCLX RESEARCH REPORT Scilex Holding Company (NASDAQ:SCLX) is a revenue-generating company that is focused on...
12 hours ago

Josi: Expand access to non-opioid pain treatments

The Detroit News
President Donald Trump made improving Americans' health a centerpiece of his 2024 campaign.
13 hours ago

New paramedicine program aims to reduce opioid-related ambulance calls in Adams County

MSN
As the opioid epidemic continues nationwide, here in the Tri-States,The Adams County Board is trying to combat it.It was revealed that the county would be...
13 hours ago

Expand Access to Non-Opioid Pain Treatments

Daily Courier
President Trump made improving Americans' health a centerpiece of his 2024 campaign. Perhaps no issue has devastated our public health more over the last 25...
20 hours ago

Scilex seeks FDA nod for ELYXYB in acute pain management

MSN
PALO ALTO, Calif. - Scilex Holding Company (NASDAQ:SCLX), a pharmaceutical company with a current market capitalization of $82.28 million and impressive...
1 day ago

Dogwood's Breakthrough Pain Drug Halneuron Targets $1.5B Cancer Market with Phase 2b Trial

Stock Titan
Dogwood Therapeutics advances non-addictive Nav 1.7 inhibitor Halneuron into Phase 2b for chemotherapy pain, backed by strong Phase 2 data from 700+...
1 day ago

New Painkiller May Be 'Landmark Development'

MSN
The FDA is expected to grant approval to a new pain medication with big potential—mainly because it's a non-opioid and is billed as non-addictive.
2 days ago

Vertex’s non-opioid drug succeeds in back pain trial

MSN
Vertex Pharmaceuticals' (NASDAQ:VRTX) investigational non-opioid drug, suzetrigine, has met the primary endpoint in a mid-stage study in people with painful...
2 days ago

Xgene’s non-opioid analgesic reduces pain in Phase IIb trial

MSN
A trial with XG005 met it's primary and secondary endpoints, demonstrating a statistically significant reduction in post-surgery pain compared to placebo.
3 days ago

Study offers a potential pathway for safer, non-addictive pain management

MSN
Researchers from the National University of Singapore (NUS), in collaboration with Peking University, China, have made a discovery regarding the TRPV1...
4 days ago